Insights On CONTRACT PHARMA MANUFACTURING
-
Get To Know WuXi Advanced Therapies Testing Services
3/21/2024
Learn how we can help you move your pipeline forward, whether you manufacture with us at WuXi Advanced Therapies, in-house, or with one of our fellow CDMOs.
-
XOFLXâ„¢ Lenti Platform: Stable Lentiviral Vector Production Cell Lines Yield LVV Titres Comparable To The Four-Plasmid Process
3/21/2024
LVV manufacturing processes remain a significant hurdle for sponsors. Review the potential of a platform of packaging and producer cell lines designed to enhance LVV manufacturing efficiency.
-
Accelerated Adventitious Virus Testing In Viral Vector Vaccines
3/21/2024
Implementing NGS technology for adventitious virus testing in viral vector vaccine development and manufacturing is crucial for ensuring safety. Gain insights for an optimized sequencing method.
-
Process Development Of High Yield, Scalable Plasmid And mRNA Manufacturing
3/21/2024
Review a successful optimization process that increases the yield of plasmids, the precursors for mRNA synthesis, and achieves a scalable, efficient process for high-quality mRNA production.
-
Scale Up Strategy For Oncolytic HSV-1 Vector Manufacturing
3/21/2024
Discover how a novel, large-scale production method for herpes simplex virus type-1 vectors has the potential to accelerate the progress of gene therapy and bring it closer to widespread application.
-
Cell Line Development For High-Titer Lentivirus Vector Production
3/21/2024
Explore a groundbreaking method to significantly enhance LV vector yield using engineered HEK293T cells. This approach paves the way for more efficient and large-scale production of LV vectors.
-
Four Steps To Identifying The CDMO Proposal Worth Signing
3/19/2024
The leap from sending your RFPs to choosing a CDMO partner requires the ability to think critically about the red flags and green flags of a given proposal.
-
Enhancing Quality By Employing Cell Line Replacement, Process Optimization
3/19/2024
Explore how the various proprietary platforms and in-house expertise fit together to enable a range of comprehensive options that can be adapted to fit development strategies.
-
Idea To Clinic: Accelerate Your Manufacturing Timeline To FIH Studies
3/11/2024
Translating novel drug discoveries into clinical trials remains a complex endeavor. Learn how a CDMO with cutting-edge technologies can facilitate a smooth path from discovery to FIH studies.
-
Accelerating The Development And Production Of High-Quality Bispecific Antibodies
3/7/2024
bsAbs are revolutionizing medicine by targeting two disease mechanisms simultaneously. Learn how an innovative platform offers excellent pairing and significantly enhances productivity and quality.